Metraipolis › archive › dc_29117bfb4ba2

Efficacy and safety of oral proprietary Chinese medicines in the treatment of stable chronic obstructive pulmonary disease: a network meta-analysis — Europe PMC PMID:41646933

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41646933
DOI
10.3389/fphar.2025.1690739
License (as archived)
solo-consultazione
Archived
2026-11-06T15:12:13.816Z
SHA-256 of the archived text
a2f0e15292de97f7dfca12867d1d784fd2f7c77b4d4d2cbed9a9c6bcdf1d4059
Stable URL of this page
https://metraipolis.com/documento/dc_29117bfb4ba2

How to cite

Efficacy and safety of oral proprietary Chinese medicines in the treatment of stable chronic obstructive pulmonary disease: a network meta-analysis — Europe PMC PMID:41646933 — Europe PMC (en), https://europepmc.org/article/MED/41646933 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_29117bfb4ba2 (Metraipolis archive dc_29117bfb4ba2, sha256 a2f0e15292de97f7dfca12867d1d784fd2f7c77b4d4d2cbed9a9c6bcdf1d4059)
BibTeX
@misc{dc29117bfb4ba2,
  title = {Efficacy and safety of oral proprietary Chinese medicines in the treatment of stable chronic obstructive pulmonary disease: a network meta-analysis — Europe PMC PMID:41646933},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41646933},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_29117bfb4ba2; sha256 a2f0e15292de97f7dfca12867d1d784fd2f7c77b4d4d2cbed9a9c6bcdf1d4059},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41646933. Agents can read the archived copy with the MCP tool read_document.